bpc-157 lagligt – Research Peptide BPC-157 – Peptide Foundry

The peptides short half-life of 4-6 hours means twice-daily dosing produces more consistent tissue levels than single daily administration

The UPLC and Synapt G2-S systems were operated with MassLynx software (Waters, Manchester), data processing and analysis were performed using MarkerLynx XS TM software

Key variables in study design include: Route of Administration: Will the compound be studied via systemic injection (subcutaneous, intramuscular) or a more localized injection near the site of injury

In stock Contents: 10 mg lyophilized (freeze-dried) powder provided in a 3 ml vial, sealed and sterile

Keep it in a dark container or the black case provided